Absence of Epidermal Antibodies in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results

Autor: Gilles F. H. Diercks, Joost M. Meijer, Maria C. Bolling, Sonja M. H. J. Scholtens-Jaegers, Jeroen Bremer, Barbara Horvath

Publikováno v: Dermatology Research and Practice, Vol 2024 (2024)

Background. Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and potentially life-threatening mucocutaneous blistering diseases that clinically can resemble autoimmune bullous diseases. Moreover, it has been shown that a

Externí odkaz: https://doaj.org/article/2dfc37585baa47bfb19328f2d3de25b9

Insights into clinical and diagnostic findings as well as treatment responses in patients with mucous membrane pemphigoid: A retrospective cohort study

Autor: Hanan Rashid, Joost M. Meijer, Maria C. Bolling, Gilles F.H. Diercks, Hendri H. Pas, Barbara Horváth

Publikováno v: Journal of the American Academy of Dermatology, 87(1), 48-55. MOSBY-ELSEVIER

The variable clinical severity of mucous membrane pemphigoid (MMP) often leads to diagnostic and therapeutic delays.To describe the characteristics of a large cohort of patients with MMP.A retrospective review of clinical and diagnostic characteristi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdf5396d16124c9700addebc2c6d808
https://doi.org/10.1016/j.jaad.2021.11.061

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg−1 per day starting dose of oral corticosteroids to treat bullous pemphigoid

Autor: J. Gottlieb, S. Debarbieux, Enno Schmidt, Jacques Benichou, Christophe Bedane, Vivien Hébert, O. Guérin, Pascal Joly, S. Bastos, Claudio Feliciani, C. Boulard, Saskia Ingen-Housz-Oro, Kossara Drenovska, Joost M. Meijer, V Ferranti, M.-A. Richard, Hana Jedličková, N. Schumacher, Michel d’Incan, G. Chaby, A. Roussel, L. Lunardon, Frédéric Caux

Publikováno v: British Journal of Dermatology
British Journal of Dermatology, In press, ⟨10.1111/bjd.20593⟩
BRITISH JOURNAL OF DERMATOLOGY, 185(6), 1232-1239. Wiley
British Journal of Dermatology, Wiley, In press, ⟨10.1111/bjd.20593⟩

BackgroundEuropean guidelines propose a 0 center dot 5 mg kg(-1) per day dose of oral prednisone as initial treatment for bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent and general condition of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8841858e0c49b2a892901e98c35220
https://hdl.handle.net/11370/a63c4e15-9086-4b60-9e13-255761b4c48a

European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I

Autor: Luca Borradori, Dedee F. Murrell, Michael Hertl, B. D. van Rhijn, M Ormond, M Roth, Valeria Mercadante, Enno Schmidt, G Geerling, Silvia Alberti-Violetti, Joost M. Meijer, Gilles F. H. Diercks, C Prost, Saaeha Rauz, Giovanna Zambruno, Jane Setterfield, Hanan Rashid, Barbara Horváth, Barbara Carey, Pascal Joly, Marzia Caproni, Frederik G. Dikkers, Hendrikus Pas, Frédéric Caux, Angelo V. Marzano, Marco Carrozzo, R J Barry, Detlef Zillikens, Giuseppe Cianchini, Alberto Corrà, G. Di Zenzo, Aniek Lamberts, Giovanni Genovese, Aikaterini Patsatsi, Claudio Feliciani

Publikováno v: Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, 35(9), 1750-1764. Wiley
Journal of the European Academy of Dermatology and Venereology, 35(10), 1926-1948. Wiley-Blackwell
Journal of the European Academy of Dermatology and Venereology, 35(9), 1750-1764. Wiley-Blackwell
Rashid, H; Lamberts, A; Borradori, L; Alberti-Violetti, S; Barry, R J; Caproni, M; Carey, B; Carrozzo, M; Caux, F; Cianchini, G; Corrà, A; Diercks, G F H; Dikkers, F G; Di Zenzo, G; Feliciani, C; Geerling, G; Genovese, G; Hertl, M; Joly, P; Marzano, A V; ... (2021). European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology-Part I. Journal of the European Academy of Dermatology and Venereology : JEADV, 35(9), pp. 1750-1764. Wiley 10.1111/jdv.17397
Journal of the European Academy of Dermatology and Venereology, 35(10), 1926-1948. Wiley

This guideline has been initiated by the task force Autoimmune Blistering Diseases of the European Academy of Dermatology and Venereology, including physicians from all relevant disciplines and patient organizations. It is a S3 consensus‐based guid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a560532849a938ba990463573c01ad9b
http://europepmc.org/articles/PMC8457055

Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid

Autor: Maria C. Bolling, Hanan Rashid, Joost M. Meijer, Barbara Horváth

Publikováno v: BRITISH JOURNAL OF DERMATOLOGY, 186(4), 721-723. Wiley

Pemphigoid is a heterogeneous group of rare and chronic autoimmune subepidermal bullous diseases, characterized by circulating autoantibodies against structural proteins in the hemidesmosomes. Long-term therapy with systemic oral prednisone and immun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b9218b0edff1fc4e745c0f378ff8ea9
https://doi.org/10.1111/bjd.20881